Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2012 08:01 ET | Source: Argos Therapeutics

Argos Therapeutics Expands Global Patent Protection

DURHAM, N.C., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
September 04, 2012 12:45 ET | Source: Argos Therapeutics

Argos Therapeutics to Present at the Stifel Nicolaus 2012 Healthcare Conference

DURHAM, N.C., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
July 02, 2012 08:00 ET | Source: Argos Therapeutics

Argos Therapeutics Receives FDA Approval of Special Protocol Assessment for AGS-003 Phase 3 Trial

DURHAM, N.C., July 2, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
June 07, 2012 08:30 ET | Source: Argos Therapeutics

Argos Therapeutics Presents Positive Phase 1a Data for AGS-009 in Patients With Lupus at 2012 EULAR Congress

DURHAM, N.C., June 7, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized and novel immunotherapies,...